{"result": "(\"entity\"<|>HICKMAN<|>ORGANIZATION<|>Hickman is a type of central venous catheter used for accessing the central circulation, associated with lower infection rates compared to non-tunneled catheters.)\n##\n(\"entity\"<|>GROSHONG<|>ORGANIZATION<|>Groshong is another type of central venous catheter designed to minimize the risk of infection.)\n##\n(\"entity\"<|>SUBCLAVIAN VEIN<|>GEO<|>The subclavian vein is a common anatomical site for central venous access, associated with lower risk of pneumothorax.)\n##\n(\"entity\"<|>INTERNAL JUGULAR VEIN<|>GEO<|>The internal jugular vein is another site for central venous access, often used in patients with significant pulmonary disease.)\n##\n(\"entity\"<|>FEMORAL VEIN<|>GEO<|>The femoral vein is also used for central venous access but has its own set of complications.)\n##\n(\"entity\"<|>SOLDINGER TECHNIQUE<|>EVENT<|>The Seldinger technique is a method used for the insertion of central venous catheters.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL<|>EVENT<|>Nutrición parenteral refers to the intravenous administration of nutrients, often requiring central venous access.)\n##\n(\"entity\"<|>MULTICENTER STUDY<|>EVENT<|>A large multicenter study focused on complications associated with non-tunneled central venous catheters in intensive care patients.)\n##\n(\"relationship\"<|>HICKMAN<|>GROSHONG<|>Both Hickman and Groshong are types of central venous catheters used to access the central circulation with a focus on reducing infection rates.<|>7)\n##\n(\"relationship\"<|>SUBCLAVIAN VEIN<|>INTERNAL JUGULAR VEIN<|>Both the subclavian vein and internal jugular vein are common sites for central venous access, each with specific advantages and disadvantages.<|>6)\n##\n(\"relationship\"<|>SUBCLAVIAN VEIN<|>FEMORAL VEIN<|>The subclavian vein and femoral vein are both anatomical sites for central venous access, but they have different risk profiles.<|>5)\n##\n(\"relationship\"<|>SOLDINGER TECHNIQUE<|>HICKMAN<|>The Seldinger technique is often used for the insertion of Hickman catheters, making it a relevant procedure in their application.<|>8)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>SUBCLAVIAN VEIN<|>Nutrición parenteral often requires central venous access, which can be achieved through the subclavian vein.<|>7)\n##\n(\"relationship\"<|>MULTICENTER STUDY<|>HICKMAN<|>The multicenter study investigated complications related to Hickman catheters, highlighting their clinical significance.<|>9)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: izado, por\nejemplo, Hickman, Groshong o un reservorio subcutá-\nneo, asociados con menor incidencia de infección si se\ncomparan con los catéteres no tunelizados.\n\n3.1. Acceso venoso central: catéteres centrales\n    no tunelizados\n\nLos catéteres centrales no tunelizados se colocan\npercutáneamente con el catéter emergiendo en la\npiel en la vecindad del lugar de canulación venosa. Se\nusan, en general, para acceder de forma temporal a\nla circulación central. Tienen distintas longitudes (de\n15 a 30 cm), están fabricados de diferentes materia-\nles (poliuretano o silicona) y pueden tener de 1 a 5\nluces (figura 1). La incidencia de trombosis venosa se\nincrementa a medida que aumenta el número de lu-\nces y el diámetro del catéter. Los catéteres venosos\ncentrales de una sola luz deben dedicarse exclusiva-\nmente a la infusión de NP, mientras que los de luces\n\n| 1 | 2 |\n|---|---|\n| 3 | 4 |\n\n1. Vía central de acceso periférico    2. Vía central de alto flujo de 5 luces\n3. Vía central de 2 luces              4. Vía central de 3 luces\n\nFigura 1. Catéteres de acceso central.\n---\nTema 49. Nutrición parenteral: vías de acceso    781\n\nmúltiples tendrán un puerto exclusivo para la infu-\nsión de la NP. También deben minimizarse las mani-\npulaciones del catéter. Estas intervenciones pueden\ndisminuir las complicaciones infecciosas asociadas\ncon la NP. La zona de inserción de la aguja debe ele-\ngirse en un área que no esté o tenga riesgo de conta-\nminarse (como piel infectada o quemada, adyacente\na traqueotomía o a herida quirúrgica abierta). La in-\nserción debe realizarse en el quirófano o en la unidad\nde cuidados intensivos, en condiciones asépticas, con\nun utillaje estéril y buena iluminación. La técnica de\ninserción es la de Seldinger. El paciente debe firmar\nun consentimiento informado.\n\nEl catéter venoso central se puede colocar en dife-\nrentes lugares anatómicos y cada uno tiene sus pro-\npias ventajas e inconvenientes (tabla 1). Los accesos\nmás utilizados son la vena subclavia, la vena yugular\ninterna (figura 2) y la femoral. Los lugares de acceso\ncon alteraciones en la anatomía local (por ejemplo,\nfractura de clavícula), cicatrices múltiples por catéter\nprevio y la presencia de otro catéter o dispositivo\nvenoso central (como marcapasos o desfibrilador\ninterno), se asocian con una incidencia mayor de\ncomplicaciones (fallo en la colocación, malposición,\narritmia), por lo que deben evitarse si hay zonas alter-\nnativas disponibles. Si el paciente tiene una enferme-\ndad pulmonar unilateral significativa, debe canularse\n\nel hemitórax ipsilateral (yugular interna, subclavia)\npara minimizar la descompensación respiratoria si hay\nun neumotórax en relación con el procedimiento. La\nanatomía de la subclavia derecha tiene la ventaja teó-\nrica de un riesgo de neumotórax más bajo, pero este\nacceso se asocia con una mayor incidencia de malpo-\nsición de catéter y trauma vascular.\n\n### 3.1.1. Acceso en subclavia versus yugular interna\n\nLas revisiones sistemáticas muestran pocas diferen-\ncias en cuanto a las principales complicaciones mecá-\nnicas entre estos dos accesos, equivalentes en cuanto\na incidencia de hemotórax y neumotórax11, 12. Aunque\nen un metaanálisis previo se sugería que el acceso no\ntunelizado en la subclavia se asociaba con menor ries-\ngo de infección relacionada con el catéter comparan-\ndo con lugares alternativos, otros estudios no han\ndemostrado diferencias significativas. Sin embargo,\nen un gran estudio multicéntrico enfocado a compli-\ncaciones intravasculares de los catéteres centrales no\ntunelizados en pacientes de cuidados intensivos, en-\ncontraron que el acceso en la subclavia estaba asocia-\ndo con un riesgo más bajo de infección y trombosis\nvenosa profunda comparando con el acceso en la\nvena yugular interna13.\n\nTabla 1. Ventajas e inconvenientes de los diferentes accesos venosos centrales.\n\n| Acceso | Ventajas | Inconvenientes |\n|---------|----------|----------------|\n| Yugular externa | · Vena superficial visible, sobre todo en ancianos<br>· No contraindicada si\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}